Fundraising FoxPangea Bio
6 known investors
Find your way into Pangea Bio
Sign up to see every warm intro you have to Pangea Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Pangea Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Pangea Bio develops therapies targeting central nervous system and mental health disorders by activating the TrkB receptor pathway to promote neuronal survival and synaptic plasticity. The company serves patients with neurological and mental health conditions.
Investors · 6
Metaplanetlisted by MetaplanetTallinn · $500K – $10M
How we know: Metaplanet's portfolio page · the VCSheet dataset · Not right? Tell us
Palo Santo VClisted by Palo Santo VC
How we know: Palo Santo VC's portfolio page · Not right? Tell us
Seaside Ventureslisted by Seaside VenturesBoulder · $250K
How we know: a partner's Signal profile · Not right? Tell us
Frequently asked questions
- What does Pangea Bio do?
- Pangea Bio develops therapies targeting central nervous system and mental health disorders by activating the TrkB receptor pathway to promote neuronal survival and synaptic plasticity. The company serves patients with neurological and mental health conditions.
- Who are Pangea Bio's investors?
- Pangea Bio's investors include Metaplanet, NO LABEL VENTURES, Palo Santo VC, Seaside Ventures, Vox Capital, XEIA Venture Partners.